BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 19523876)

  • 21. Cystine-knot peptides: emerging tools for cancer imaging and therapy.
    Ackerman SE; Currier NV; Bergen JM; Cochran JR
    Expert Rev Proteomics; 2014 Oct; 11(5):561-72. PubMed ID: 25163524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NMR as a tool for elucidating the structures of circular and knotted proteins.
    Craik DJ; Daly NL
    Mol Biosyst; 2007 Apr; 3(4):257-65. PubMed ID: 17372654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel miniproteins engineered by the transfer of active sites to small natural scaffolds.
    Vita C; Vizzavona J; Drakopoulou E; Zinn-Justin S; Gilquin B; Ménez A
    Biopolymers; 1998; 47(1):93-100. PubMed ID: 9692330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conformation and mode of membrane interaction in cyclotides. Spatial structure of kalata B1 bound to a dodecylphosphocholine micelle.
    Shenkarev ZO; Nadezhdin KD; Sobol VA; Sobol AG; Skjeldal L; Arseniev AS
    FEBS J; 2006 Jun; 273(12):2658-72. PubMed ID: 16817894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cystine-knot peptides targeting cancer-relevant human cytotoxic T lymphocyte-associated antigen 4 (CTLA-4).
    Maaß F; Wüstehube-Lausch J; Dickgießer S; Valldorf B; Reinwarth M; Schmoldt HU; Daneschdar M; Avrutina O; Sahin U; Kolmar H
    J Pept Sci; 2015 Aug; 21(8):651-60. PubMed ID: 25964162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidative folding of peptides with cystine-knot architectures: kinetic studies and optimization of folding conditions.
    Reinwarth M; Glotzbach B; Tomaszowski M; Fabritz S; Avrutina O; Kolmar H
    Chembiochem; 2013 Jan; 14(1):137-46. PubMed ID: 23229141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclotides: a patent review.
    Smith AB; Daly NL; Craik DJ
    Expert Opin Ther Pat; 2011 Nov; 21(11):1657-72. PubMed ID: 22017409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemical synthesis, backbone cyclization and oxidative folding of cystine-knot peptides: promising scaffolds for applications in drug design.
    Reinwarth M; Nasu D; Kolmar H; Avrutina O
    Molecules; 2012 Oct; 17(11):12533-52. PubMed ID: 23095896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Engineering stabilized vascular endothelial growth factor-A antagonists: synthesis, structural characterization, and bioactivity of grafted analogues of cyclotides.
    Gunasekera S; Foley FM; Clark RJ; Sando L; Fabri LJ; Craik DJ; Daly NL
    J Med Chem; 2008 Dec; 51(24):7697-704. PubMed ID: 19053834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protease-resistant peptide ligands from a knottin scaffold library.
    Getz JA; Rice JJ; Daugherty PS
    ACS Chem Biol; 2011 Aug; 6(8):837-44. PubMed ID: 21615106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cycloviolacin H4, a hydrophobic cyclotide from Viola hederaceae.
    Chen B; Colgrave ML; Wang C; Craik DJ
    J Nat Prod; 2006 Jan; 69(1):23-8. PubMed ID: 16441062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation, characterization, and bioactivity of cyclotides from the Micronesian plant Psychotria leptothyrsa.
    Gerlach SL; Burman R; Bohlin L; Mondal D; Göransson U
    J Nat Prod; 2010 Jul; 73(7):1207-13. PubMed ID: 20575512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineered knottin peptides as diagnostics, therapeutics, and drug delivery vehicles.
    Kintzing JR; Cochran JR
    Curr Opin Chem Biol; 2016 Oct; 34():143-150. PubMed ID: 27642714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclotides, a novel ultrastable polypeptide scaffold for drug discovery.
    Gould A; Ji Y; Aboye TL; Camarero JA
    Curr Pharm Des; 2011 Dec; 17(38):4294-307. PubMed ID: 22204428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural plasticity of the cyclic-cystine-knot framework: implications for biological activity and drug design.
    Clark RJ; Daly NL; Craik DJ
    Biochem J; 2006 Feb; 394(Pt 1):85-93. PubMed ID: 16300479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amino acid requirement for the high affinity binding of a selected arginine-rich peptide with the HIV Rev-response element RNA.
    Sugaya M; Nishino N; Katoh A; Harada K
    J Pept Sci; 2008 Aug; 14(8):924-35. PubMed ID: 18351707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery and applications of the plant cyclotides.
    Craik DJ
    Toxicon; 2010 Dec; 56(7):1092-102. PubMed ID: 20219513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation and improvement of the properties of the novel cystine-knot microprotein McoEeTI for oral administration.
    Werle M; Kafedjiiski K; Kolmar H; Bernkop-Schnürch A
    Int J Pharm; 2007 Mar; 332(1-2):72-9. PubMed ID: 17070661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Backbone cyclization of a recombinant cystine-knot peptide by engineered Sortase A.
    Stanger K; Maurer T; Kaluarachchi H; Coons M; Franke Y; Hannoush RN
    FEBS Lett; 2014 Nov; 588(23):4487-96. PubMed ID: 25448598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fragmentation follows structure: top-down mass spectrometry elucidates the topology of engineered cystine-knot miniproteins.
    Reinwarth M; Avrutina O; Fabritz S; Kolmar H
    PLoS One; 2014; 9(10):e108626. PubMed ID: 25303319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.